Missing child Sana Fathima’s body recovered from river

New Delhi, Jan 2: India on Sunday reported the second case of novel coronavirus with a person from Kerala with a travel history to China testing positive, officials said.

"The patient has tested positive for novel coronavirus and is in isolation in a hospital," the health ministry said.

The patient is stable and is being closely monitored, it said.

India's first novel coronavirus case in India was also reported from Kerala with a student testing positive.

Bengaluru, Jan 9: Primary and Secondary Education Minister S Suresh Kumar on Thursday said that the Education Department would launch a helpline by March 2020 to address the complaints.

Speaking to reporters here, he said, the helpline is not only for children but also for teachers.

"Entire department including teachers and parents can make use of the opportunity”, the minister said.

“The helpline can be called for any complaint related to the Education Department. Our objective is to resolve problems within a stipulated time,” the Minister said.

Mangaluru, May 23: Criticising the Karnataka government's fresh protocol for management of Covid-19 as expensive, a prominent physician in the city has demanded its withdrawal.

According to Dr B Srinivas Kakkilaya, the protocol released by the Health and Family Welfare Department on May 15 enlists unnecessary and unconfirmed tests and treatments. 

The protocol has classified Covid-19 cases into three categories and has provided for hospitalisation of all three categories of patients, from asymptomatic to the most severely ill.

In a letter to the government, Dr Kakkilaya said: "The protocol suggests several investigations to be done right on the day of admission, including blood counts, liver and renal function tests, chest X Ray, ECG, CT scan of the chest, and other special investigations, all of which, if done, will cost Rs 25,000 per patient."

"In the coming days when lakhs of patients are likely to be infected with SARS CoV2, is it necessary and feasible to hospitalise and test all these patients at Rs 25,000 per person," he questioned.

The treatment options suggested in the protocol are also surprising, he pointed out. "The protocol recommends choloroquine, azithromycin, oseltamivir, zinc and vitamin C for all patients, from asymptomatic to the severely ill, and also anti coagulant injections for many patients. All these would cost at least Rs 5,000 per patient. For severe cases of Covid-19, many unproven and experimental treatments have been suggested, which are very expensive and highly questionable," Dr Kakkilaya notes.

Therefore, this protocol, he asserted was not evidence based and likely to do more harm than good. He said these unnecessarily expensive tests and allowing private companies to conduct trials on Covid-19 patients is likely to be misused by vested interests and must be immediately withdrawn, and instead, a protocol that is evidence-based, simple and avoiding unnecessary expenses, must be developed.